Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer.

NCT07730151 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Prostate
Prostate Cancer Patients

Interventions

DRUG: Darolutamide
DRUG: docetaxel
DRUG: ADT

Sponsor

RenJi Hospital

Collaborators

[object Object]